April 11, 2026
What Form 4 Is and Why It Matters Section 16 of the Securities Exchange Act requires corporate insiders — officers, directors, and anyone owning more than 10% of a company — to report changes in their beneficial ownership within two business days of each transaction. Form 4 is that report. Two business days between an […]
Read More →
April 11, 2026
Squeezes Are Mechanical Events A short squeeze is a mechanical consequence of a specific set of market conditions: too many short sellers in a stock with insufficient float to exit cleanly. When those conditions exist at sufficient intensity and a catalyst triggers covering demand, the outcome is predictable in direction if not in timing or […]
Read More →
April 11, 2026
Why Options Flow Is a Leading Indicator Large, informed participants — institutions, hedge funds, and occasionally those with non-public information — frequently establish options positions before moving in equity. Options provide leverage, define maximum loss, and leave a smaller footprint than equivalent equity positions. The result is a flow of options data that, when read […]
Read More →
April 11, 2026
What a PDUFA Date Actually Is The Prescription Drug User Fee Act requires the FDA to review New Drug Applications (NDAs) and Biologics License Applications (BLAs) within a set timeframe — typically 10 months for standard review, 6 months for priority review. The PDUFA date is the FDA’s self-imposed deadline to complete that review. It […]
Read More →
April 11, 2026
Why Manual EDGAR Monitoring Doesn’t Work Anymore The SEC’s EDGAR database is public. Every S-3, S-1, 424B, ATM shelf registration, and warrant exercise notice is sitting there — filed, timestamped, and technically available to anyone. The problem isn’t access. The problem is speed and volume. EDGAR processes thousands of filings per day. If you’re trading […]
Read More →
March 24, 2026
Read More →
March 24, 2026
Read More →
March 24, 2026
Read More →
March 24, 2026
Read More →
March 24, 2026
Read More →